Compare Edwards Lifesciences Corporation Common Stock (EW) vs Progressive Corp (PGR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Progressive Corp — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.19 (market cap $48.56B), while Progressive Corp trades at $217.5 (market cap $126.95B). The key difference: Progressive Corp is far larger — about 2.6× Edwards Lifesciences Corporation Common Stock's market cap, and Progressive Corp pays a 0.18% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | PGR | |
|---|---|---|
Market Cap | $48.56B | $126.95B |
Volume | 6,520,488 | 2,749,438 |
Sector | Health | Financials |
52-Week High | $95.18 | $242.16 |
52-Week Low | $72.65 | $190.40 |
Enterprise Value | $45.01B | $135.16B |
Typical Hold Time | — | 81 Days |
Dividend Yield | — | 0.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Progressive Corporation (PGR) trades at $217.43, up 1.55% with a bullish technical outlook supported by moving averages and strong institutional interest. The company demonstrates robust fundamentals with revenue growing from $49.6B in 2022 to $87.6B in 2025, net income reaching $11.3B, and impressive profitability metrics including 34.94% ROE. Recent earnings show mixed results with Q2 2026 beating expectations while Q1 2026 missed, with Q3 2026 results pending.
The stock presents a compelling value opportunity with a P/E of 10.97 and positive analyst sentiment (38.1% buy ratings), though competitive pressures in auto insurance and potential market volatility pose risks. With a consensus price target of $222.23 offering modest upside, PGR remains well-positioned for long-term growth given its operational strength and dividend consistency.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Progressive Corp
Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →
